-
Something wrong with this record ?
Treatment of Takotsubo cardiomyopathy
T. Palecek, P. Kuchynka, A. Linhart,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
- MeSH
- Adrenergic beta-Antagonists therapeutic use MeSH
- Catecholamines blood MeSH
- Humans MeSH
- Stress, Psychological complications psychology therapy MeSH
- Takotsubo Cardiomyopathy etiology psychology therapy MeSH
- Treatment Outcome MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Takotsubo cardiomyopathy (TC) is a condition most prevalent in postmenopausal women, characterized by transient left ventricular dysfunction following acute emotional or physical stress. Direct catecholamine-mediated myocyte injury and microvascular dysfunction leading to myocardial stunning are believed to play a major role in its pathogenesis. The treatment of TC remains empirical. In the acute phase, therapy must be individualized depending on hemodynamic situation. In stable conditions, it appears advantageous to prevent excessive sympathetic activation by combining alpha and beta blockade. Beta blockers are used to treat dynamic left ventricular obstruction. Phenylephrine may represent an alternative approach in patients presenting with outflow tract obstruction and severe hypotension. In hemodynamically unstable patients, early administration of intra-aortic balloon pump counterpulsation should be considered. As no consensus currently exists with respect to the chronic management of TC, randomized clinical trials are urgently needed with focus on treatment strategies.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027980
- 003
- CZ-PrNML
- 005
- 20121207093345.0
- 007
- ta
- 008
- 120817s2010 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.2174/138161210793176455 $2 doi
- 035 __
- $a (PubMed)20632951
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Paleček, Tomáš, $d 1971- $7 uk2008438218 $u Charles University of Prague, 1st Medical Faculty, 2nd Medical Department - Department of Cardiovascular Medicine, Prague, Czech Republic. tpalec@lf1.cuni.cz
- 245 10
- $a Treatment of Takotsubo cardiomyopathy / $c T. Palecek, P. Kuchynka, A. Linhart,
- 520 9_
- $a Takotsubo cardiomyopathy (TC) is a condition most prevalent in postmenopausal women, characterized by transient left ventricular dysfunction following acute emotional or physical stress. Direct catecholamine-mediated myocyte injury and microvascular dysfunction leading to myocardial stunning are believed to play a major role in its pathogenesis. The treatment of TC remains empirical. In the acute phase, therapy must be individualized depending on hemodynamic situation. In stable conditions, it appears advantageous to prevent excessive sympathetic activation by combining alpha and beta blockade. Beta blockers are used to treat dynamic left ventricular obstruction. Phenylephrine may represent an alternative approach in patients presenting with outflow tract obstruction and severe hypotension. In hemodynamically unstable patients, early administration of intra-aortic balloon pump counterpulsation should be considered. As no consensus currently exists with respect to the chronic management of TC, randomized clinical trials are urgently needed with focus on treatment strategies.
- 650 _2
- $a beta blokátory $x terapeutické užití $7 D000319
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a katecholaminy $x krev $7 D002395
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a psychický stres $x komplikace $x psychologie $x terapie $7 D013315
- 650 _2
- $a takotsubo kardiomyopatie $x etiologie $x psychologie $x terapie $7 D054549
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kuchynka, Petr, $d 1978- $7 xx0083628
- 700 1_
- $a Linhart, Aleš, $d 1964- $7 mzk2003188958
- 773 0_
- $w MED00007893 $t Current pharmaceutical design $x 1873-4286 $g Roč. 16, č. 26 (2010), s. 2905-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20632951 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121207093419 $b ABA008
- 999 __
- $a ok $b bmc $g 950022 $s 785326
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 16 $c 26 $d 2905-9 $i 1873-4286 $m Current pharmaceutical design $n Curr Pharm Des $x MED00007893
- LZP __
- $a Pubmed-20120817/11/03